Wire · technology
Insilico Medicine introduces inClinico Agent: An agentic AI system designed to accelerate ...
◆ Sectors
◆ Source
◆ Verified
Fusion42 · 23 October 2026 · Fusion42 review
Insilico Medicine launched inClinico Agent, an agentic AI platform that automates clinical trial intelligence and predicts trial outcomes using a proprietary database and machine learning models, achieving high accuracy and regulatory-grade workflow integration.
This Wire brief sits within Fusion42's coverage of AI Agents, Biotech and Drug Discovery.
◆ ◆ The Wire takeaway
You can cut months of clinical trial analysis into minutes with AI that also handles regulatory documents. This tool means your drug development decisions get faster and more reliable, helping you beat competitors who still rely on expert guesswork.
◆ Coverage
1 source · 23 Oct 2026
◆ Related on Wire
◆ Topics